The Biotech Winter Finally Thaws
The resurgence in both IPO activity and M&A transactions may mark the beginning of what I believe will be...
Sign-up for curated market briefs covering bleeding-edge tech breakthroughs, market-moving stocks, and institutional intel typically reserved for hedge funds. Every Monday, Wednesday & Friday, before the opening bell
The resurgence in both IPO activity and M&A transactions may mark the beginning of what I believe will be...
Clearly, rate expectations are changing. That means we’re in for an interesting second half of the year.
The market isn't waiting for diplomats to finalize every detail.
Second-quarter reporting season begins in earnest in mid-July…
We’re seeing the leading edge of the reshoring wave… and it’s only beginning.
Part of trading (and investing) successfully is looking for opportunities few see… not piling in with the masses.